Nasal high‐flow therapy versus NIV in COPD patients with chronic respiratory failure
31.4 هزار بار بازدید -
5 سال پیش
-
To access the manuscript:
To access the manuscript: https://onlinelibrary.wiley.com/doi/f...
McKinstry, S, Singer, J, Baarsma, JP, Weatherall, M, Beasley, R, Fingleton, J. Nasal high‐flow therapy compared with non‐invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross‐over trial. Respirology. 2019; 1– 7. https://doi.org/10.1111/resp.13575
SUMMARY: Non‐invasive ventilation (NIV) reduces transcutaneous partial pressure of carbon dioxide (PtCO2) more than nasal high‐flow (NHF) therapy in hypercapnic COPD, but NHF is better tolerated.
Video produced by the Medical Research Association of New Zealand (MRINZ). Medical Illustration by Dr Ciléin Kearns (Artibiotics).
McKinstry, S, Singer, J, Baarsma, JP, Weatherall, M, Beasley, R, Fingleton, J. Nasal high‐flow therapy compared with non‐invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross‐over trial. Respirology. 2019; 1– 7. https://doi.org/10.1111/resp.13575
SUMMARY: Non‐invasive ventilation (NIV) reduces transcutaneous partial pressure of carbon dioxide (PtCO2) more than nasal high‐flow (NHF) therapy in hypercapnic COPD, but NHF is better tolerated.
Video produced by the Medical Research Association of New Zealand (MRINZ). Medical Illustration by Dr Ciléin Kearns (Artibiotics).
5 سال پیش
در تاریخ 1398/02/29 منتشر شده
است.
31,443
بـار بازدید شده